Skip to content

Thermo Fisher Scientific TMO Repayments of Long-Term Debt

Repayments of Long-Term Debt at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$12.0B
Operating income$2.1B
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$214.21B+17.7%
Enterprise value$249.32B+16.0%
P/E30.8×+3.1×
P/S4.8×-0.9×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.

The official record: Thermo Fisher Scientific’s 8-K, filed July 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Thermo Fisher Scientific's repayments of long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Thermo Fisher Scientific's repayments of long-term debt?
Thermo Fisher Scientific (TMO) reported repayments of long-term debt of -$2.82B in Q2 2026.
How has Thermo Fisher Scientific's repayments of long-term debt changed year-over-year?
Thermo Fisher Scientific's repayments of long-term debt decreased by 458.8% year-over-year, from $787M to -$2.82B.
What is the long-term trend for Thermo Fisher Scientific's repayments of long-term debt?
Over 2 years (2023 to 2025), Thermo Fisher Scientific's repayments of long-term debt has grown at a -35.4% compound annual growth rate (CAGR), from $5.78B to $2.41B.